Oncolys BioPharma Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	54,830	12,881	10,878	9,130	9,171	21,971
Market Cap Growth	326.49%	18.41%	19.14%	-0.44%	-58.26%	-19.57%
Enterprise Value	53,817	11,569	9,991	7,125	5,757	20,418
Last Close Price	1873.00	518.00	567.00	527.00	528.00	1503.00
PS Ratio	1920.76	410.43	172.56	9.35	14.27	69.93
PB Ratio	30.96	4.68	7.38	4.23	2.55	10.97
P/TBV Ratio	30.96	4.68	7.38	4.23	2.55	10.97
EV/Sales Ratio	-	368.62	158.50	7.30	8.96	64.99
Debt / Equity Ratio	0.19	0.12	0.21	0.18	0.14	0.26
Asset Turnover	0.01	0.01	0.03	0.28	0.18	0.09
Inventory Turnover	-	-	2.19	35.52	40.10	6.15
Quick Ratio	5.19	10.14	4.32	6.19	8.91	5.38
Current Ratio	6.62	12.28	5.17	8.11	9.76	6.13
Return on Equity (ROE)	-110.09%	-79.73%	-106.71%	-39.94%	-57.72%	-76.78%
Return on Assets (ROA)	-55.37%	-40.26%	-51.44%	-22.01%	-26.86%	-29.41%
Return on Invested Capital (ROIC)	-345.38%	-365.97%	-351.64%	-164.69%	-276.12%	-306.97%
Return on Capital Employed (ROCE)	-108.70%	-57.30%	-116.20%	-52.50%	-39.40%	-70.90%
Earnings Yield	-3.75%	-13.08%	-17.82%	-12.58%	-17.61%	-9.54%
FCF Yield	-	-15.71%	-12.34%	-18.82%	-19.01%	-6.68%
Buyback Yield / Dilution	-21.76%	-22.67%	-2.71%	-2.44%	-17.54%	-3.41%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.